Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Endotoxin Tests
    • 1.2.1.2 Sterility Tests
    • 1.2.1.3 Cell Line Authentication and Characterization Tests
    • 1.2.1.4 Bioburden Tests
    • 1.2.1.5 Cell Line Authentication
    • 1.2.1.6 Residual Host Contaminant Detection Tests
    • 1.2.1.7 Adventitious Agent Detection Tests
    • 1.2.1.8 Others
  • 1.2.2 by Application
    • 1.2.2.1 Vaccine Development
    • 1.2.2.2 Blood Products Testing
    • 1.2.2.3 Cellular & Gene Therapy
    • 1.2.2.4 Tissue and Tissue-Related Products Testing
    • 1.2.2.5 Stem Cell Research
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Endotoxin Tests Market, 2013-2018
  • 4.1.2 Sterility Tests Market, 2013-2018
  • 4.1.3 Cell Line Authentication and Characterization Tests Market, 2013-2018
  • 4.1.4 Bioburden Tests Market, 2013-2018
  • 4.1.5 Cell Line Authentication Market, 2013-2018
  • 4.1.6 Residual Host Contaminant Detection Tests Market, 2013-2018
  • 4.1.7 Adventitious Agent Detection Tests Market, 2013-2018
  • 4.1.8 Others Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Endotoxin Tests Market Forecast, 2019-2024
  • 4.2.2 Sterility Tests Market Forecast, 2019-2024
  • 4.2.3 Cell Line Authentication and Characterization Tests Market Forecast, 2019-2024
  • 4.2.4 Bioburden Tests Market Forecast, 2019-2024
  • 4.2.5 Cell Line Authentication Market Forecast, 2019-2024
  • 4.2.6 Residual Host Contaminant Detection Tests Market Forecast, 2019-2024
  • 4.2.7 Adventitious Agent Detection Tests Market Forecast, 2019-2024
  • 4.2.8 Others Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Vaccine Development Market, 2013-2018
  • 5.1.2 Blood Products Testing Market, 2013-2018
  • 5.1.3 Cellular & Gene Therapy Market, 2013-2018
  • 5.1.4 Tissue and Tissue-Related Products Testing Market, 2013-2018
  • 5.1.5 Stem Cell Research Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Vaccine Development Market Forecast, 2019-2024
  • 5.2.2 Blood Products Testing Market Forecast, 2019-2024
  • 5.2.3 Cellular & Gene Therapy Market Forecast, 2019-2024
  • 5.2.4 Tissue and Tissue-Related Products Testing Market Forecast, 2019-2024
  • 5.2.5 Stem Cell Research Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Lonza Group
• 8.2 Charles River
• 8.3 Merck
• 8.4 SGS
• 8.5 WuXi AppTec
• 8.6 Thermo Fisher Scientific
• 8.7 Sartorius
• 8.8 Cytovance Biologics
• 8.9 Pace Analytical Services
• 8.10 Toxikon

9 Conclusion

Summary
The global Biologics Safety Testing market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Vaccine Development
Blood Products Testing
Cellular & Gene Therapy
Tissue and Tissue-Related Products Testing
Stem Cell Research
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa